Brief: Century Therapeutics Reports Qtrly Loss Per Share $0.66
16/05/2022 13:31
May 16 (Reuters) - Century Therapeutics Inc IPSC.O :
* CENTURY THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATES
* CENTURY THERAPEUTICS INC - ENDED Q1 2022 WITH CASH, CASH
EQUIVALENTS, AND INVESTMENTS OF $466.4M; CASH RUNWAY INTO 2025
* CENTURY THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.66
Source text for Eikon: ID:nGNX9HqpFK
Further company coverage: IPSC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Century Therapeutics
See all newsCentury Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Century Therapeutics Q2 net loss misses estimates on lease termination loss
Brief: Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 Million
Century Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Century Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview